Reference health

Drug Delivery Across the Blood–Brain Barrier

https://doi.org/10.1016/b978-0-08-088504-9.00180-x
CiteStamped reference-health badge
27/27 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 27 checked references that resolve
resolves10.1371/journal.pmed.0030442
Projections of Global Mortality and Burden of Disease from 2002 to 2030
resolves10.1111/j.2042-7158.1996.tb07112.x
The Blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System
resolves10.1021/jm701122q
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
resolves10.1016/j.nbd.2009.07.030
Structure and function of the blood–brain barrier
resolves10.1073/pnas.85.2.632
Transcytotic pathway for blood-borne protein through the blood-brain barrier.
resolves10.1208/s12248-008-9055-2
CNS Delivery Via Adsorptive Transcytosis
resolves10.1111/j.1471-4159.2004.02385.x
Clearing amyloid through the blood–brain barrier
resolves10.1006/mvre.1999.2188
Microvessel Organization and Structure in Experimental Brain Tumors: Microvessel Populations with Distinctive Structural and Functional Properties
resolves10.3171/foc.2006.20.4.8
Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomas
resolves10.1016/0378-5173(89)90266-4
The effect of polysorbate 80 on brain uptake and analgesic effect of D-kyotorphin
resolves10.1016/S0361-9230(03)00043-1
Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport
resolves10.1016/S0301-5629(01)00521-X
High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo
resolves10.1016/j.addr.2008.03.010
Ultrasound for drug and gene delivery to the brain
resolves10.1007/BF00687316
Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier
resolves10.1073/pnas.91.15.7114
Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.
resolves10.1046/j.1471-4159.2001.00541.x
Restricted transport of anti‐transferrin receptor antibody (OX26) through the blood–brain barrier in the rat
resolves10.1016/0896-6273(93)90070-8
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
resolves10.1038/bjp.2008.260
Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep‐2
resolves10.1016/S0022-3565(25)20727-3
Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier.
resolves10.1021/bc049730c
Polypeptide Point Modifications with Fatty Acid and Amphiphilic Block Copolymers for Enhanced Brain Delivery
resolves10.1126/science.1529356
A Strategy for Delivering Peptides into the Central Nervous System by Sequential Metabolism
resolves10.1016/j.addr.2007.03.008
shRNA and siRNA delivery to the brain
resolves10.1089/104303403322168019
<i>In Vivo</i> Delivery of Glial Cell-Derived Neurotrophic Factor Across the Blood-Brain Barrier by Gene Transfer into Brain Capillary Endothelial Cells
resolves10.1016/0378-5173(90)90047-8
Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants
resolves10.1021/bc034164r
Nanogels for Oligonucleotide Delivery to the Brain
resolves10.1021/bm0604000
Carbohydrate-Based Micelle Clusters Which Enhance Hydrophobic Drug Bioavailability by Up to 1 Order of Magnitude
resolves10.1016/j.regpep.2009.01.002
Intranasal administration of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, enhances total uptake and bioavailability in Swiss Webster mice when compared to intraperitoneal, subcutaneous, and intramuscular delivery systems
The 3 references without a DOI — listed, not checked
no DOI — not checkedPharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain
no DOI — not checkedIncreased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas
no DOI — not checkedUchegbu IF, Schatzlein AG, and Lalatsa A (2010) Oral Delivery of Hydrophilic Drugs to the Brain. WO/2010/100479, 1 March 2010.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/b978-0-08-088504-9.00180-x"><img src="https://citestamp.com/citestamped/10.1016/b978-0-08-088504-9.00180-x/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/b978-0-08-088504-9.00180-x/badge.svg)](https://citestamp.com/citestamped/10.1016/b978-0-08-088504-9.00180-x)